Product image of Linezolid Polpharma (Linezolid) supplied by GNH India

Linezolid Polpharma

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Polpharma (Linezolid)

Linezolid, the active ingredient in Linezolid Polpharma, is an oxazolidinone presented as an oral formulation for systemic use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients. It is indicated for a range of serious bacterial infections and is administered orally, providing an alternative to intravenous therapy when appropriate.

GNH India supplies Linezolid Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established logistics for regulated markets and adherence to quality standards.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat several serious bacterial infections.

  • Complicated skin and skin structure infections: effective treatment of infections caused by susceptible Gram‑positive organisms, including MRSA.
  • Community‑acquired bacterial pneumonia: helps eradicate the causative pathogen and improve respiratory outcomes.
  • Nosocomial pneumonia: provides coverage against resistant strains in hospital‑acquired lung infections.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: active against MRSA strains in various infection sites.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an oral option for infections caused by VRE.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This binding prevents the formation of the initiation complex, thereby blocking the translation of essential proteins and halting bacterial growth. The action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations. Because the target site is not present in human cells, linezolid exhibits selective activity with minimal impact on host protein synthesis.

Side Effects

Linezolid may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste sensation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: nerve damage presenting as tingling or numbness.
  • Optic neuropathy: visual disturbances that may be irreversible.
  • Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.

Precautions & Warnings

Before initiating linezolid therapy, several safety considerations should be reviewed.

  • Renal impairment: assess kidney function and adjust monitoring as needed.
  • Hepatic impairment: evaluate liver enzymes and monitor for hepatotoxicity.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform regular complete blood count monitoring.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Linezolid interacts with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate severe serotonin toxicity.
  • Rifampin: induces metabolism and reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: linezolid can increase INR, requiring dose adjustment.
  • Phenytoin: may lower linezolid levels, reducing efficacy.
  • NSAIDs: combined use may increase bleeding risk.

Frequently Asked Questions

Linezolid Polpharma is used to treat serious infections caused by susceptible Gram‑positive bacteria, including complicated skin and skin‑structure infections, community‑acquired and nosocomial pneumonia, as well as infections due to methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

Linezolid works by binding to the bacterial 50S ribosomal subunit, preventing the formation of the initiation complex needed for protein synthesis. This blocks the production of essential proteins, inhibiting bacterial growth and, at higher concentrations, can kill the organism.

The prescribing healthcare professional determines the dose of linezolid based on the specific infection, its severity, patient weight, renal and hepatic function, and other clinical factors. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for linezolid in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Linezolid Polpharma, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral coverage against resistant Gram‑positive organisms, whereas alternatives such as vancomycin are typically administered intravenously. Linezolid provides a convenient oral option with activity against MRSA and VRE, but it requires monitoring for hematologic and neurologic adverse effects that are less common with some alternatives.

Linezolid Polpharma should be stored at below 25 °C in its original packaging, protected from moisture and direct heat. Keep the product out of reach of children and avoid exposure to excessive humidity.

Linezolid is administered orally, usually as tablets or oral suspension, and can be taken with or without food. The exact method of administration should follow the prescriber’s directions.

Serious risks include thrombocytopenia, peripheral and optic neuropathy, and serotonin syndrome, especially when combined with serotonergic medications. Patients should be monitored regularly for blood‑count changes, neurological symptoms, and any signs of excessive serotonergic activity.

Linezolid should not be used by individuals with known hypersensitivity to linezolid or other oxazolidinones, and it is contraindicated in patients currently receiving monoamine oxidase inhibitors. Caution is also advised for patients with pre‑existing blood‑count disorders or severe renal/hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT